Article History
First Online: 27 February 2019
Compliance with Ethical Standards
:
: No sources of funding were used to assist in the preparation of this review.
: Author RDS is a site investigator for multicenter trials with Shire and Astellas, and has received grant support from Veloxis, Novartis, Merck. RDS has served on speaker bureaus for Veloxis and Alexion, received royalties from UpToDate. RDS’s family member has stock in Pfizer. Author DC is the site principal investigator for multicenter trials with Janssen, Fibrogen, GSK, Medibeacon, and Astra Zeneca. DC receives consulting fees from Fresenius, Vifor, Medibeacon, GSK and Reata. DC has participated in review activities for Aspire Bariatrics and participated in lectures/speaker bureaus for Fresenius Medical Care-Renal Therapies Group. Author AR and Author TTM declare that they have no disclosures.